For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarterit ...

The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...

Skin Envy explains Semaglutide and Tirzepatide ...

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

With Hims & Hers' main source of growth set to be extinguished, Citi analysts said its full-year guidance appeared ...

“As time goes on, they’re more willing to share their story because they get so many compliments,” she said. “The person who is next to them says, ‘Tell me your secret,’ and they may whisper my name ...

If you've experienced fatigue, difficulty sleeping, weight gain, reduced sex drive and even hair loss, you're not alone. These are common symptoms experienced by both men and women as we age -- and ...

People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...